Recently, a tissue microarray analysis showed that adding chromogranin to synaptophysin detects an extra 4.2% of breast cancer cases with neuroendocrine differentiation, while INSM1 identifies 15% of cases negative for both (22). This evidence concerns the gene SYP and breast cancer.